| India | Turchia | Austria | |
| Terapia radiante per sarcomi | da $4,500 | da $3,250 | da $18,000 |
| Terapia protonica per il cancro alla prostata | da $35,000 | da $30,000 | da $80,000 |
| Terapia protonica per il cancro al seno | da $26,000 | da $30,000 | da $55,000 |
| Terapia con protoni | da $25,000 | da $70,000 | da $80,000 |
| Radioterapia per il cancro colorettale | da $3,200 | da $7,000 | da $12,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Sarcoma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Sarcoma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Sarcoma.
Il medico è un oncochirurgo altamente qualificato con una vasta esperienza in chirurgia oncologica. Specializzandosi in interventi chirurgici complessi per il cancro, il medico ha guidato numerosi interventi di successo che hanno migliorato significativamente i risultati dei pazienti. Con un focus su tecniche chirurgiche innovative e cura personalizzata del paziente, il medico ha contribuito ai progressi nel campo dell'oncologia. Il medico è anche riconosciuto per la sua leadership nel Dipartimento di Chirurgia Oncologica, dove supervisiona un team dedicato al trattamento e alla ricerca sul cancro all'avanguardia.<\/p>
Il medico ha ricevuto una formazione in Oncologia Chirurgica presso il Tata Memorial Hospital di Mumbai e ha completato il MRCS al Royal College of Surgeons di Edimburgo. Iniziando la pratica nel 2000, il medico ha fondato il Curie Manavata Cancer Centre nel 2007. Con 19 anni di esperienza, il medico ha eseguito oltre 50.000 interventi chirurgici per il cancro e ha partecipato a più di 200 studi clinici. Il medico è un autore pubblicato con numerose pubblicazioni internazionali e nazionali. Specializzandosi in Oncologia Chirurgica della Mammella e Toracica, il medico è professore per DNB Superspecialty Surgical Oncology e Breast Surgery presso MUHS.<\/p>
Il dottore ha completato un MD in Medicina Interna presso il Shyam Shah Medical College e ha svolto una Residenza Senior nello stesso dipartimento. Successivamente, il dottore ha servito come Registrar in Oncologia Medica presso il Jawaharlal Nehru Cancer Hospital. Il dottore ha completato la formazione DNB in Oncologia Medica presso l'Indraprastha Apollo Hospital.<\/p>
Durante la Residenza Senior, il dottore ha tenuto lezioni alla Scuola Internazionale Invernale di Oncologia presso l'AIIMS e ha presentato ricerche sul Cancro allo Stomaco al Simposio sul Cancro Gastrointestinale della Società Americana di Oncologia Clinica. Il dottore è specializzato nella base molecolare del cancro e nelle terapie mirate.<\/p>
La dottoressa è un'oncologa altamente qualificata specializzata nel trattamento di vari tipi di cancro, inclusi tumori solidi, tumori pediatrici e malignità ematologiche. È esperta in trattamenti sia conservativi che chirurgici, come la procedura di Whipple.<\/p>
Ha completato il suo MBBS al Lady Hardinge Medical College e il MD in medicina interna al Maulana Azad Medical College. Ha proseguito con il DM in Oncologia Medica al Tata Memorial Hospital, dove ha anche lavorato come consulente.<\/p>
È affiliata a società oncologiche internazionali e nazionali e ha esperienza in tumori polmonari, mammari, ginecologici e genitourinari, con un particolare interesse per l'immunoterapia e la terapia metronomica.<\/p>
Sarcoma is curable in India when diagnosed early and treated at specialized orthopedic oncology centers. Localized soft tissue sarcomas show 70% to 90% survival rates. Bone sarcomas like osteosarcoma reach 60% to 80% survival with multimodal protocols combining limb-sparing surgery, targeted chemotherapy, and radiation.
Bookimed Expert Insight: India excels in high-volume surgical expertise that directly impacts survival. Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 surgeries and leads extensive clinical trials. This volume allows Indian surgeons to master complex limb-salvage techniques that preserve function while ensuring clear tumor margins. For patients seeking the highest safety standards, Fortis Gurgaon is ranked among the most technically advanced hospitals globally.
Patient Consensus: Patients emphasize the need to visit specialized oncology units in major cities like Delhi or Chennai to avoid common misdiagnoses. Many travelers note that starting the coordinated chemotherapy and surgery phases without delays is vital for the best recovery outcome.
Limb-salvage surgery for sarcoma is widely available in India at specialized tertiary centers. It is highly successful. Surgeons preserve the limb in 90% to 95% of bone cancer cases. Most centers report 5-year survival rates exceeding 80% for bone cancers like osteosarcoma.
Bookimed Expert Insight: Indian hospitals like Manipal and Apollo allow for complex reconstructions because they integrate orthopedic oncology with plastic surgery teams. Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. This high surgeon volume is a key indicator of success. Large networks like Apollo serve 1,000,000 patients annually. This helps them maintain lower infection rates and better functional outcomes.
Patient Consensus: Patients emphasize that early referral to a major oncology center is vital. They note that staying in urban centers for intensive physical therapy ensures a better return to normal activities.
Sarcoma surgery in India typically lasts 3 to 8 hours depending on tumor size and location. Limb-sparing resections often take 3 to 6 hours. Complex bone sarcoma procedures may exceed 8 hours. Most patients remain hospitalized for 3 to 7 days for initial monitoring and pain management.
Bookimed Expert Insight: Data from high-volume Indian centers shows a high concentration of expertise, with surgeons like Dr. Raj Nagarkar performing over 50,000 procedures. This massive volume often leads to efficient surgical timelines despite the complexity of sarcoma cases. While hospitals like Global Hospital Chennai report discharging patients as early as day 4, international patients should plan for a 10-day local stay to ensure all surgical drains are safely removed before travel.
Patient Consensus: Patients note that while the first 48 hours involve significant swelling, starting mobility exercises by day 2 is vital. Many emphasize having home help ready for the first 10 days to manage limited mobility and fatigue.
Specialized sarcoma care in India is available at JCI-accredited centers like Apollo Hospital Indraprastha and Manipal Hospitals. These facilities utilize multidisciplinary teams including orthopedic oncologists and radiation specialists. Key treatments include limb-sparing surgery, proton therapy, and high intensity focused ultrasound ablation (HIFU).
Bookimed Expert Insight: Patient volume data suggests choosing a network like Manipal Hospitals or Apollo Hospitals. These groups serve over 1,000,000 patients annually. High surgical volume often correlates with better outcomes for rare sarcomas. For example, Dr. Raja Sundaram at Global Hospital Chennai has handled 15,000+ cancer surgeries. Large facilities also ensure access to nuclear medicine experts like Dr. Chaitainya Borde for critical PET-CT staging.
Patient Consensus: Patients note it's important to travel to major cities for specialized orthopedic oncologists. They emphasize that initial treatment plans must be right to avoid complications and suggest seeking hospitals where oncology subspecialties are fully integrated.
Patients traveling for sarcoma treatment in India must provide original pathology slides, biopsy blocks, and physical imaging discs. You need a valid passport, medical visa, and comprehensive diagnostic reports. All non-English documents require notarized translations to ensure immediate oncological review and registration at high-volume medical centers.
Bookimed Expert Insight: India hosts massive medical networks like Manipal Hospitals and Apollo Hospitals, which together serve over 3,000,000 patients annually. Because of this extreme volume, centers like Fortis Gurgaon prioritize patients who provide ready-to-review digital DICOM files. Bringing these raw files instead of just printed films can prevent a 4-day wait for re-imaging and data processing.
Patient Consensus: Patients emphasize that missing original biopsy slides or having only printed scans often causes a 2-week delay. They note that digitizing everything into folders and carrying three physical copies ensures smoother consultations at major centers.
Limbs can be saved in up to 95% of bone sarcoma cases in India. Surgeons use Limb Salvage Surgery to achieve these high preservation rates. They remove tumours while maintaining structural integrity. Teams use modular prostheses and 3D-printed implants to preserve function in arms and legs.
Bookimed Expert Insight: Patient volume often dictates technical mastery in salvage cases. Manipal Hospitals serves 2,000,000 patients annually. This scale allows surgical teams to handle rare anatomical reconstructions. When saving a limb, choosing these high-volume facilities often leads to better functional results.
Patient Consensus: Patients in India recommend seeking a second opinion before accepting amputation. They note that recovery usually feels more positive than losing a limb entirely, even with reduced function.
Sarcoma treatment in India is effective for metastatic disease through a multidisciplinary approach. Major centres use proton-beam therapy, robotic surgery, and targeted systemic therapies. Success depends on the specific sarcoma type and spread. Specialist teams manage cases with PET-CT diagnostics and precise radiotherapy.
Bookimed Expert Insight: Indian oncology centres often offer high-density nuclear medicine capabilities. Dr. Chaitainya Borde at HCG Manavata has managed 30,000+ PET scans. This volume suggests that clinics there have deep experience in tracking metastatic spread. Accurate staging through such experience is vital for planning effective systemic therapy.
Patient Consensus: Patients note it is important to clarify if the treatment goal is disease control or symptom relief in India. Finding a dedicated sarcoma multidisciplinary team matters more than general oncology services.
Sarcoma treatment in India typically begins 1 to 2 weeks after the first specialist consultation. Major oncology hubs expedite aggressive cases within days of a confirmed diagnosis. JCI-accredited facilities in Delhi and Bengaluru streamline care through multidisciplinary tumour board reviews and on-site diagnostic laboratories.
Bookimed Expert Insight: Patients can reduce wait times by providing pathology slides and digital imaging files before arrival. Clinics like Manipal Hospitals use IBM Watson for clinical decision support. This helps specialists cross-reference complex sarcoma data faster. This preparation often allows doctors to move straight to treatment planning rather than repeating basic diagnostics.
Patient Consensus: Patients note that treatment starts quicker when arriving with complete records. Bringing original biopsy slides for Indian pathology reviews prevents delays and avoids the need for repeat biopsies.
Sarcoma treatment in India typically lasts from 3 weeks to 12 months. Soft tissue sarcomas often require 3 weeks to 3 months. Bone sarcomas, including Ewing’s sarcoma, generally follow longer protocols spanning 9 to 12 months. The specific timeline depends on the cancer subtype and stage.
Bookimed Expert Insight: Indian centres like Manipal Hospitals and Apollo Hospital Indraprastha treat many international patients. Their high volume allows for rapid diagnostic turnaround. While bone sarcoma protocols are long, patients may return to Australia between chemotherapy cycles. This flexible approach is common at JCI-accredited facilities in Gurgaon and Bengaluru.
Patient Consensus: Patients note that sarcoma care in India is multi-stage and highly variable. Many recommend asking for a full timeline including recovery gaps. This is because chemotherapy cycles extend the duration well beyond the initial surgery.
Australian patients should look for Indian centres with Joint Commission International (JCI) accreditation. They should also seek a dedicated sarcoma multidisciplinary team. Priority should be given to hospitals offering limb-sparing surgery. Patients should check for PET-CT diagnostics and surgeons with high-volume experience in tumours.
Bookimed Expert Insight: Patients should focus on hospitals that combine high surgical volume with deep diagnostic infrastructure. For example, Manipal Hospitals serves 2,000,000 patients annually and uses IBM Watson for oncology. This scale often means the facility manages rare sarcoma subtypes more frequently than smaller clinics. Selecting a centre with an on-site research complex, such as Medanta, can provide faster staging protocols.
Patient Consensus: Patients emphasise the need for expert pathology re-reviews in India. This helps to ensure the sarcoma subtype is correctly identified before surgery. They suggest confirming the clinic provides digital records and pathology blocks. This makes the handover to Australian specialists seamless.